VirB8: a conserved type IV secretion system assembly factor and drug targetThis paper is one of a selection of papers published in this Special Issue, entitled CSBMCB — Membrane Proteins in Health and Disease.
- 1 December 2006
- journal article
- review article
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 84 (6) , 890-899
Abstract
Type IV secretion systems are used by many Gram-negative bacteria for the translocation of macromolecules (proteins, DNA, or DNA–protein complexes) across the cell envelope. Among them are many pathogens for which type IV secretion systems are essential virulence factors. Type IV secretion systems comprise 8–12 conserved proteins, which assemble into a complex spanning the inner and the outer membrane, and many assemble extracellular appendages, such as pili, which initiate contact with host and recipient cells followed by substrate translocation. VirB8 is an essential assembly factor for all type IV secretion systems. Biochemical, cell biological, genetic, and yeast two-hybrid analyses showed that VirB8 undergoes multiple interactions with other type IV secretion system components and that it directs polar assembly of the membrane-spanning complex in the model organism Agrobacterium tumefaciens. The availability of the VirB8 X-ray structure has enabled a detailed structure–function analysis, which identified sites for the binding of VirB4 and VirB10 and for self-interaction. Due to its multiple interactions, VirB8 is an excellent model for the analysis of assembly factors of multiprotein complexes. In addition, VirB8 is a possible target for drugs that target its protein–protein interactions, which would disarm bacteria by depriving them of their essential virulence functions.Keywords
This publication has 64 references indexed in Scilit:
- Targeting Bacterial Secretion Systems: Benefits of Disarmament in the MicrocosmInfectious Disorders - Drug Targets, 2007
- Type IV secretion systems and their effectors in bacterial pathogenesisCurrent Opinion in Microbiology, 2006
- Agrobacterium tumefaciens VirB8 structure reveals potential protein–protein interaction sitesProceedings of the National Academy of Sciences, 2006
- From bioremediation to biowarfare: On the impact and mechanism of type IV secretion systemsFEMS Microbiology Letters, 2005
- Energetic components VirD4, VirB11 and VirB4 mediate early DNA transfer reactions required for bacterial type IV secretionMolecular Microbiology, 2004
- Virulence as a target for antimicrobial chemotherapyExpert Opinion on Investigational Drugs, 2002
- Structural basis for the interaction between NTF2 and nucleoporin FxFG repeatsThe EMBO Journal, 2002
- Bacterial virulence as a target for antimicrobial chemotherapyCurrent Opinion in Biotechnology, 2000
- The lipoprotein VirB7 interacts with VirB9 in the membranes of Agrobacterium tumefaciensJournal of Bacteriology, 1997
- Agrobacterium tumefaciens VirB7 and VirB9 form a disulfide-linked protein complex.Proceedings of the National Academy of Sciences, 1996